Goldman Sachs Initiates LifePoint Health With Conviction Buy

Analysts at Goldman Sachs initiated coverage on LifePoint Health Inc LPNT with a Conviction Buy rating. The target price for LifePoint Health is set to $92. LifePoint Health shares have gained 13.78 percent over the past 52 weeks, while the S&P 500 index has surged 7.51 percent in the same period. LifePoint Health shares fell 1.05 percent to close at $73.39 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: InitiationAnalyst RatingsGoldman SachsHealth CareHealth Care Facilities
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!